Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients After Kawasaki Disease: A Systematic Review and Meta-Analyses

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Jul 11

PMID 26161871

Citations 16

Authors

Sanne M Dietz

Carline E A Tacke

Barbara A Hutten

Taco W Kuijpers

Affiliations

Soon will be listed here.

Abstract

Background: Kawasaki disease (KD) is a systemic pediatric vasculitis. Its main complication is the development of coronary arterial aneurysms (CAA), causing an increased risk for ischemia and myocardial infarction. It is unclear whether KD patients, apart from the presence of CAA, have an increased cardiovascular disease (CVD) risk due to the previous systemic vasculitis. The aim of this study was to systematically review and meta-analyse the literature regarding surrogate markers for CVD risk in KD patients.

Methods: Medline and Embase were searched for articles comparing endothelial dysfunction (flow-mediated dilation, nitroglycerin-mediated dilation and peripheral arterial tonometry), vascular stiffness (stiffness index, pulse wave velocity) and carotid intima-media thickness (cIMT) between patients and controls. Two investigators assessed the articles for eligibility and evaluated quality.

Results: Thirty studies were included. For all outcomes, moderate to high heterogeneity between studies was found. Most studies reported a decreased flow-mediated dilation in the whole KD- and CAA-positive group compared to controls, while data on CAA-negative patients were conflicting. The stiffness index was increased in the majority of studies evaluating the whole KD- and CAA-positive group, but not in most studies on CAA-negative patients. Mean cIMT was neither significantly increased in the whole KD-group nor in the CAA-positive group nor in most studies studying CAA-negative patients. Studies measuring maximum cIMT were conflicting.

Conclusion: Literature suggests that surrogate markers for CVD risk in KD patients are increased in CAA-positive but not in CAA-negative patients. This may indicate that CAA-positive patients should be monitored for CVD in later life. The results of this review have to be interpreted with care due to substantial heterogeneity between studies and methodological limitations, as well as the lack of long-term follow-up studies.

Citing Articles

Assessment of Endothelial Dysfunction in Patients with Kawasaki Disease: A Meta-Analysis.

Yu X, Wu D, Song G Rev Cardiovasc Med. 2024; 23(8):260.

PMID: 39076622 PMC: 11266953. DOI: 10.31083/j.rcm2308260.

Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitis.

Hatamnejad M, Karvandi M, Jodatfar F, Ebrahimi N, Shojaeian F, Ghavami S Front Med (Lausanne). 2023; 9:1008711.

PMID: 36687438 PMC: 9853977. DOI: 10.3389/fmed.2022.1008711.

Endothelial Peripheral Arterial Tonometry (Endo-PAT 2000) use in paediatric patients: a systematic review.

Hayden J, ODonnell G, deLaunois I, OGorman C BMJ Open. 2023; 13(1):e062098.

PMID: 36657756 PMC: 9853225. DOI: 10.1136/bmjopen-2022-062098.

Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study.

Robinson C, Chanchlani R, Gayowsky A, Brar S, Darling E, Demers C Pediatr Res. 2022; 93(5):1267-1275.

PMID: 36380069 DOI: 10.1038/s41390-022-02391-3.

Ultrasound evaluation of endothelial dysfunction in immunoglobulin-resistant children with acute Kawasaki disease.

Wen Y, Yang Y, Wen Y, Xi J, Chen T, Lu Y Clin Rheumatol. 2022; 41(12):3797-3805.

PMID: 35982351 DOI: 10.1007/s10067-022-06341-6.

References

Niboshi A, Hamaoka K, Sakata K, Yamaguchi N . Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr. 2007; 167(2):189-96. DOI: 10.1007/s00431-007-0452-9. View

Cheung Y, Ho M, Tam S, Yung T . Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart. 2004; 90(11):1281-5. PMC: 1768534. DOI: 10.1136/hrt.2003.018507. View

de Jongh S, Lilien M, Roodt J, Stroes E, Bakker H, Kastelein J . Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002; 40(12):2117-21. DOI: 10.1016/s0735-1097(02)02593-7. View

Buckley D, Fu R, Freeman M, Rogers K, Helfand M . C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151(7):483-95. DOI: 10.7326/0003-4819-151-7-200910060-00009. View

Deng Y, Xiang H, Chang Q, Li C . Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J. 2002; 66(10):908-12. DOI: 10.1253/circj.66.908. View

Liu X, Huang G, Liang X, Ma X . Endothelial progenitor cells and arterial functions in the late convalescence period of Kawasaki disease. Acta Paediatr. 2009; 98(8):1355-9. DOI: 10.1111/j.1651-2227.2009.01334.x. View

Pahkala K, Heinonen O, Simell O, Viikari J, Ronnemaa T, Niinikoski H . Association of physical activity with vascular endothelial function and intima-media thickness. Circulation. 2011; 124(18):1956-63. DOI: 10.1161/CIRCULATIONAHA.111.043851. View

McCrindle B, McIntyre S, Kim C, Lin T, Adeli K . Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?. J Pediatr. 2007; 151(3):244-8, 248.e1. DOI: 10.1016/j.jpeds.2007.03.056. View

Lorenz M, von Kegler S, Steinmetz H, Markus H, Sitzer M . Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2005; 37(1):87-92. DOI: 10.1161/01.STR.0000196964.24024.ea. View

10.

Cheung Y, Wong S, Ho M . Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child. 2006; 92(1):43-7. PMC: 2083125. DOI: 10.1136/adc.2006.096628. View

11.

Tobayama H, Takahashi K, Fukunaga H, Matsui K, Tanaka N, Harada M . Analysis of arterial function in adults with a history of Kawasaki disease. J Cardiol. 2013; 61(5):330-5. DOI: 10.1016/j.jjcc.2012.12.007. View

12.

Hamburg N, Palmisano J, Larson M, Sullivan L, Lehman B, Vasan R . Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension. 2011; 57(3):390-6. PMC: 3049726. DOI: 10.1161/HYPERTENSIONAHA.110.160812. View

13.

Kadono T, Sugiyama H, Hoshiai M, Osada M, Tan T, Naitoh A . Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol. 2005; 26(4):385-90. DOI: 10.1007/s00246-004-0755-9. View

14.

Noto N, Okada T, Abe Y, Miyashita M, Kanamaru H, Karasawa K . Characteristics of earlier atherosclerotic involvement in adolescent patients with Kawasaki disease and coronary artery lesions: significance of gray scale median on B-mode ultrasound. Atherosclerosis. 2012; 222(1):106-9. DOI: 10.1016/j.atherosclerosis.2012.01.049. View

15.

Dawson J, Sonka M, Blecha M, Lin W, Davis P . Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the Muscatine Offspring Study. J Am Coll Cardiol. 2009; 53(24):2273-9. PMC: 2747309. DOI: 10.1016/j.jacc.2009.03.026. View

16.

Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K . Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol. 2008; 30(3):262-8. DOI: 10.1007/s00246-008-9329-6. View

17.

Rubinshtein R, Kuvin J, Soffler M, Lennon R, Lavi S, Nelson R . Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010; 31(9):1142-8. DOI: 10.1093/eurheartj/ehq010. View

18.

Oguri M, Nakamura T, Tamanuki K, Akita C, Kitaoka C, Saikawa Y . Subclinical arterial stiffness in young children after Kawasaki disease. Cardiol Young. 2013; 24(1):87-94. DOI: 10.1017/S1047951112002302. View

19.

Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T . Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000; 101(25):2935-41. DOI: 10.1161/01.cir.101.25.2935. View

20.

Huang S, Weng K, Chang J, Lee W, Huang S, Hsieh K . Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study. Circ J. 2008; 72(10):1583-7. DOI: 10.1253/circj.cj-08-0121. View